– USA, CA – TRIO Pharmaceuticals, a biotechnology company advancing novel multi-functional antibody treatments for cancers with high unmet medical need, announced the appointment of Dr.…
– USA, PA – Traws Pharma, Inc. (NASDAQ: TRAW), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, announced the appointment of Dr.…
– USA, CA – Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, announced the appointment of Hervé Hoppenot as Chairman of its Board of Directors, succeeding Dr.…
– USA, MA – Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, announced the appointment of Brian Posner to its Board of Directors, bringing 35 years of executive, investment, and board leadership expertise to the company.…
– USA, CA – Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced the appointment of David Moore to its Board of Directors, bringing a wealth of experience from his 27-year career in the industry, including broad expertise across strategy, commercial, market access, business development and investing from working in both large cap pharmaceutical and biotech companies and within private equity.…